IO in High-Risk Early HCC
Immunotherapy-Based Combinations as (Neo)Adjuvant Treatment in High-Risk HCC

Released: May 29, 2024

Expiration: May 28, 2025

Mark Yarchoan
Mark Yarchoan, MD

Activity

Progress
1
Course Completed